Literature DB >> 32013747

Polyclonal lymphocytic infiltrate with arachnoiditis resulting from intrathecal stem cell transplantation.

Ajay A Madhavan1, Dan Summerfield2, Christopher H Hunt1, Dong K Kim1, Karl N Krecke1, Aditya Raghunathan2, John C Benson1.   

Abstract

Stem cell treatment outside of studied and approved medical indications can have unforeseen adverse consequences. Here, we present a 74-year-old male that underwent such therapy. The patient presented to our institution with progressive lower extremity weakness and urinary incontinence. He had previously undergone intrathecal stem cell therapy in Moscow, Russia for weakness and fatigue. Magnetic resonance imaging of his thoracic and lumbar spine showed marked enlargement of the cauda equina nerve roots and abnormal mass-like soft tissue involving the thoracolumbar thecal sac. Surgical biopsy of the intrathecal soft tissue showed polyclonal lymphocytic and glial cell proliferation. The patient's symptoms did not improve with medical treatment or radiation, and he is currently under observation after multidisciplinary evaluation. Our patient's experience illustrates one of the potential risks of "stem cell tourism" and exemplifies the imaging and histopathologic features of this rare entity. We also compare our patient's treatment with other similar examples of stem cell treatments in our institution and others. These have had a wide spectrum of results. In some instances, intrathecal stem cells have caused abnormal imaging findings without any associated patient symptoms. In extreme examples, however, stem cell treatments have resulted in central nervous system neoplasms. Our patient's lesion is quite unique, with only one similar lesion having been previously published.

Entities:  

Keywords:  glial cell proliferation; intrathecal; stem cell; stem cell tourism

Mesh:

Year:  2020        PMID: 32013747      PMCID: PMC7140295          DOI: 10.1177/1971400920902451

Source DB:  PubMed          Journal:  Neuroradiol J        ISSN: 1971-4009


  16 in total

1.  Press release. "Stem Cell Implants to Treat Spinal Cord Injury: No Scientific Evidence, Beware of Hope Thieves".

Authors:  Giuseppe Carannante
Journal:  Neuroradiol J       Date:  2010-04-20

2.  The Experience and Health-Related Quality of Life after Haploidentical Stem Cell Transplantation for Adults with Sickle Cell Disease.

Authors:  Brooklyn Hastings; Crystal Patil; Agatha M Gallo
Journal:  West J Nurs Res       Date:  2019-08-18       Impact factor: 1.967

Review 3.  Concise Review: A Comprehensive Analysis of Reported Adverse Events in Patients Receiving Unproven Stem Cell-Based Interventions.

Authors:  Gerhard Bauer; Magdi Elsallab; Mohamed Abou-El-Enein
Journal:  Stem Cells Transl Med       Date:  2018-07-31       Impact factor: 6.940

4.  Glioproliferative Lesion of the Spinal Cord as a Complication of "Stem-Cell Tourism".

Authors:  Aaron L Berkowitz; Michael B Miller; Saad A Mir; Daniel Cagney; Vamsidhar Chavakula; Indira Guleria; Ayal Aizer; Keith L Ligon; John H Chi
Journal:  N Engl J Med       Date:  2016-06-22       Impact factor: 91.245

Review 5.  Cancer Stem Cells Equipped with Powerful Hedgehog Signaling and Better Epigenetic Memory: Avenues to Look for Cancer Therapeutics.

Authors:  Ishita Tandon; Asawari Waghmode; Nilesh Kumar Sharma
Journal:  Curr Cancer Drug Targets       Date:  2019       Impact factor: 3.428

6.  Magnetic resonance imaging tractography as a diagnostic tool in patients with spinal cord injury treated with human embryonic stem cells.

Authors:  Geeta Shroff
Journal:  Neuroradiol J       Date:  2017-01-06

7.  Factors Associated With Overall Survival in Acute Myeloid Leukemia Patients Before and After Hematopoietic Stem Cell Transplant.

Authors:  Pelin Aytan; Mahmut Yeral; Asli Korur; Cigdem Gereklioglu; Mutlu Kasar; Nur Hilal Buyukkurt; Suheyl Asma; Ilknur Kozanoglu; Hakan Ozdogu; Can Boga
Journal:  Exp Clin Transplant       Date:  2019-08-19       Impact factor: 0.945

8.  Safety of intrathecal autologous adipose-derived mesenchymal stromal cells in patients with ALS.

Authors:  Nathan P Staff; Nicolas N Madigan; Jonathan Morris; Mark Jentoft; Eric J Sorenson; Greg Butler; Dennis Gastineau; Allan Dietz; Anthony J Windebank
Journal:  Neurology       Date:  2016-10-26       Impact factor: 9.910

9.  Ovarian Cancer Stem Cells with High ROR1 Expression Serve as a New Prophylactic Vaccine for Ovarian Cancer.

Authors:  Di Wu; Xiaoyu Yu; Jing Wang; Xu Hui; Yunxia Zhang; Yunlang Cai; Mulan Ren; Mei Guo; Fengshu Zhao; Jun Dou
Journal:  J Immunol Res       Date:  2019-03-17       Impact factor: 4.818

10.  Donor-derived brain tumor following neural stem cell transplantation in an ataxia telangiectasia patient.

Authors:  Ninette Amariglio; Abraham Hirshberg; Bernd W Scheithauer; Yoram Cohen; Ron Loewenthal; Luba Trakhtenbrot; Nurit Paz; Maya Koren-Michowitz; Dalia Waldman; Leonor Leider-Trejo; Amos Toren; Shlomi Constantini; Gideon Rechavi
Journal:  PLoS Med       Date:  2009-02-17       Impact factor: 11.069

View more
  3 in total

Review 1.  The leptomeninges as a critical organ for normal CNS development and function: First patient and public involved systematic review of arachnoiditis (chronic meningitis).

Authors:  Carol S Palackdkharry; Stephanie Wottrich; Erin Dienes; Mohamad Bydon; Michael P Steinmetz; Vincent C Traynelis
Journal:  PLoS One       Date:  2022-09-30       Impact factor: 3.752

Review 2.  International stem cell tourism: a critical literature review and evidence-based recommendations.

Authors:  Samantha Lyons; Shival Salgaonkar; Gerard T Flaherty
Journal:  Int Health       Date:  2022-03-02       Impact factor: 2.473

3.  Stem cell induced inflammatory hypertrophy of the cauda equina.

Authors:  Aaron D Brumbaugh; Alan Podolsky; Matthew H Kulzer; Michael P Spearman; Michael F Goldberg; Warren M Chang; Nazia Khatoon; Kossivi Dantey; Charles Q Li
Journal:  Radiol Case Rep       Date:  2022-03-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.